Shares of Stryker Co. (NYSE:SYK) reached a new 52-week high on Thursday . The stock traded as high as $193.13 and last traded at $192.89, with a volume of 22165 shares changing hands. The stock had previously closed at $191.84.

Several analysts recently weighed in on the company. Canaccord Genuity increased their price target on Stryker from $185.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, January 30th. Zacks Investment Research upgraded Stryker from a “hold” rating to a “buy” rating and set a $199.00 price target on the stock in a report on Monday, February 4th. Morgan Stanley decreased their price target on Stryker from $212.00 to $197.00 and set an “overweight” rating on the stock in a report on Wednesday, January 2nd. Royal Bank of Canada increased their price target on Stryker from $184.00 to $204.00 and gave the company an “outperform” rating in a report on Monday. Finally, Cantor Fitzgerald restated a “neutral” rating on shares of Stryker in a report on Friday, January 18th. Seven equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $188.35.

The stock has a market cap of $71.49 billion, a P/E ratio of 26.42, a price-to-earnings-growth ratio of 2.34 and a beta of 0.88. The company has a quick ratio of 1.41, a current ratio of 2.02 and a debt-to-equity ratio of 0.72.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Tuesday, January 29th. The medical technology company reported $2.18 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.15 by $0.03. The company had revenue of $3.80 billion for the quarter, compared to the consensus estimate of $3.73 billion. Stryker had a return on equity of 27.60% and a net margin of 26.12%. On average, equities analysts predict that Stryker Co. will post 8.13 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Friday, March 29th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 1.08%. The ex-dividend date of this dividend is Thursday, March 28th. Stryker’s payout ratio is 28.45%.

In related news, insider Timothy J. Scannell sold 5,282 shares of the company’s stock in a transaction on Wednesday, January 16th. The stock was sold at an average price of $163.50, for a total transaction of $863,607.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Katherine Ann Owen sold 29,247 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $185.62, for a total value of $5,428,828.14. Following the sale, the vice president now owns 11,131 shares of the company’s stock, valued at $2,066,136.22. The disclosure for this sale can be found here. Insiders have sold a total of 74,811 shares of company stock worth $13,409,320 in the last three months. Corporate insiders own 7.30% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of SYK. ERTS Wealth Advisors LLC purchased a new stake in Stryker in the fourth quarter valued at about $25,000. Northwest Wealth Management LLC raised its stake in Stryker by 103.6% in the fourth quarter. Northwest Wealth Management LLC now owns 169 shares of the medical technology company’s stock valued at $26,000 after buying an additional 86 shares during the last quarter. Semmax Financial Advisors Inc. purchased a new stake in Stryker in the fourth quarter valued at about $28,000. Horan Securities Inc. purchased a new stake in Stryker in the fourth quarter valued at about $30,000. Finally, Truehand Inc purchased a new stake in Stryker in the fourth quarter valued at about $30,000. Hedge funds and other institutional investors own 75.46% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Stryker (SYK) Reaches New 1-Year High at $193.13” was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.dailypolitical.com/2019/03/14/stryker-syk-reaches-new-1-year-high-at-193-13.html.

Stryker Company Profile (NYSE:SYK)

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

See Also: How are Outstanding Shares Different from Authorized Shares?

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.